Wanbury share news, announcements and annual reports
NSE: WANBURYBSE: 524212Pharmaceuticals & BiotechnologySmall Cap
Wanbury Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1992 on BSE, Jan 2007 on NSE
Last close ₹181.93up ₹7.77 (4.46%)BSE ₹180.55
Share price at the NSE close on 29 Oct 2026. Previous close ₹174.16.
29 Oct: open ₹174.92, high ₹185.01, low ₹172.63
52-week range of traded prices to 29 Oct 2026
₹161.50Low, 27 Jan 2026₹358.85High, 15 Jul 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹636 Cr1,555th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 11.38
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.40
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 54.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 23.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.49
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,72,76957.0% delivered
Wanbury board meetings
160 filed, newest first. Page 3 of 4.
May 2016
18 May · Board meeting
Apr 2016
Jan 2016
Nov 2015
Oct 2015
Sep 2015
28 Sep · Board meeting
Aug 2015
Jul 2015
May 2015
Jan 2015
29 Jan · Board meeting
Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter ended December 31, 2014.
Nov 2014
14 Nov · Board meeting
Inter alia, to consider and take on record the Audited Financial Results of the Company for the financial year 2013-14 i.e. from April 1, 2013 to September 30, 2014.
Jul 2014
22 Jul · Board meeting
Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the fifth quarter and fifteen months ended June 30, 2014.
May 2014
Jan 2014
28 Jan · Board meeting
Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the third quarter and nine months ended on December 31, 2013.
Oct 2013
18 Oct · Board meeting
Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2013.
Jul 2013
23 Jul · Board meeting
Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the first quarter ended June 30, 2013.
May 2013
30 May · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2013 have approved the following: (1) Appointment of Mr.S.K.Bhattacharyya, former Managing Director of State Bank of India as an Additional Director; (2) Appointment of Mr.Manish Joshi in place of Mr.P.R.Dalal as Exim Bank nominee; and (3) Resignation of Mr.Sundaresh Bhat as CFO of the Company.16 May · Board meeting
Inter alia, to consider and take on record the Audited Financial Results of the Company for the financial year 2012-13.
Feb 2013
7 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 07, 2013 has approved restructuring of business by way of transferring the Formulation business to a subsidiary of the Company subject to the approval of the Bankers of the Company and other regulatory authorities.
Jan 2013
28 Jan · Board meeting
Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the third quarter and nine months ended on December 31, 2012.
Oct 2012
29 Oct · Board meeting
Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the second quarter and half year ended on September 30, 2012.
Jul 2012
27 Jul · Board meeting
Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the first quarter ended June 30, 2012.
May 2012
30 May · Board meeting
Vide its letter dated May 28, 2012 that Mr. Ashok Shinkar has resigned from the position of Director of the Company.
Feb 2012
2 Feb · Board meeting
Inter alia, to consider and take on record the Unaudited Financial Results of the company for the third quarter and nine months ended on December 31, 2011.
Oct 2011
28 Oct · Board meeting
Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the second quarter and half year ended on September 30, 2011.
Sep 2011
20 Sep · Board meeting
Inter alia, to consider "annexure prescribed with the cost audit report" for the financial year ended on March 31, 2011.
May 2011
11 May · Board meeting
Inter alia, to consider the Audited Financial Results of the Company for the financial year 2010-2011 i.e. from April 01, 2010 to March 31, 2011.
Jan 2011
21 Jan · Board meeting
Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the third quarter and nine months ended on December 31, 2010.
Oct 2010
21 Oct · Board meeting
Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the second quarter and half year ended on September 30, 2010.
Jul 2010
20 Jul · Board meeting
Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the first quarter ended on June 30, 2010.
May 2010
21 May · Board meeting
Inter-alia, to consider the Audited Financial Results of the Company for the financial year 2009-2010 i.e. from April 01, 2009 to March 31, 2010.
Jan 2010
11 Jan · Board meeting
Interalia, to consider and take on record the Unaudited Financial Results of the Company for the third quarter and nine months ended on December 31, 2009.
Dec 2009
24 Dec · Board meeting
Board of Directors of the Company at their meeting held on December 23, 2009 has inter alia, approved the following: (i) Conversion of Cash Credit Limit of Rs. 5.50 Crore of Andhra Bank into Foreign Currency Loan- WCDL. (ii) Conversion of Rs.9.0 Crore Working Capital Demand Loan/ Cash Credit facility (WCDL) of State Bank of India into Foreign Currency Loan. (iii) Draft Rehabilitation Scheme for the Merger of Pharmaceutical Products of India Limited with the Company.(iv) Employee Stock Option Scheme for the employees of the Company. (v) Taking approval of the Shareholders of the Company and for the Draft Rehabilitation Scheme for the Merger of Pharmaceutical Products of India Limited with the Company and for the Employee Stock Option Scheme through Postal Ballot Route.21 Dec · Board meeting
Company had informed the Exchange regarding the Board meeting scheduled to be held on December 21, 2009, inter-alia to consider (1) conversion of Corporate Term Loan of Bank of India into Foreign Currency Term Loan (2) conversion of Cash Credit Limit of Andhra Bank into Foreign Currency Loan- WCDL. The Company has now informed the Exchange that "The meeting of Board of Directors of the Company scheduled for today i.e. December 21, 2009, has been postponed due to some unavoidable reasons. The meeting will be held on December 23, 2009".15 Dec · Board meeting
Inter-alia to consider (1) conversion of Corporate Term Loan of Bank of India into Foreign Currency Term Loan (2) conversion of Cash Credit Limit of Andhra Bank into Foreign Currency Loan- WCDL.
Oct 2009
15 Oct · Board meeting
Interalia, to consider the Unaudited Financial Results of the Company for the second quarter and half year ended on September 30, 2009.
Sep 2009
29 Sep · Board meeting
Vide its letter dated September 29, 2009 that the Board of Directors of the Company at its meeting just concluded, has inter alia approved the following: (1) Cost Audit Report of the Company for the financial year 2008-2009 i.e. for the 6 months period from October 01, 2008 to March 31, 2009. (2) Appointment of Mr. P.R. Dalal as Nominee Director of Export Import Bank of India in the place of Mr.Sudip Bhattacharyya. (3) Appointment of Mr. K.R.N. Moorthy as Joint Managing Director of the Company for a period of 3 years w.e.f. 29th September, 2009, subject to the approval of the shareholders through Postal Ballot. (4) Appointment of Dr. Rajaram Samant as an Additional Director and also Whole Time Director of the Company for a period of 3 years w.e.f. 29th September, 2009, subject to the approval of the shareholders through Postal Ballot.18 Sep · Board meeting
Inter alia to consider the Cost Audit Report of the Company for the financial year 2008-2009 i.e. for the 6 months period from October 01, 2008 to March 31, 2009.
Jul 2009
17 Jul · Board meeting
Interalia, to consider the Unaudited Financial Results of the Company for the first quarter ended June 30, 2009.
Jun 2009
23 Jun · Board meeting
Inter alia, to consider the Audited Financial Results of the Company for the financial year 2008-2009 i.e. for the 6 months period from October 01, 2008 to March 31, 2009.5 Jun · Board meeting
Board of Directors of the Company at their meeting held on June 03, 2009 has inter alia, approved the following : 1) Availing Term Loan of Rs. 19.5 Crore and working capital facility of Rs. 11 Crore (Fund Based Working Capital Facility of Rs. 7 Crore and Non-fund Based Working Capital Facility of Rs. 4 Crore) from State Bank of Mysore. 2) Availing Fund Based Working Capital Facility of Rs. 9.50 Crore and Non-fund Based Working Capital Facility of Rs. 7.90 Crore from Bank of India.
May 2009
28 May · Board meeting
Inter alia, to consider the following : 1) Availing Term Loan of Rs. 19.5 Crore and working capital facility of Rs. 11 Crore (Fund Based Working Capital Facility of Rs. 7 Crore and Non- Fund Based Working Capital Facility of Rs. 4 ) from State Bank of Mysore. 2) Availing Fund based Working Capital facility of Rs. 9.50 Crore and Non-fund Based Working Capital Facility of Rs. 7.90 Crore from Bank of India.
Jan 2009
20 Jan · Board meeting
Meeting on 30 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Dec 2008
23 Dec · Board meeting
Inter alia, to consider the following: (1) Dividend for the 18 months period ended as on September 30, 2008. (2) Annual Accounts for the 18 months period ended as on September 30, 2008 (i.e. from April 01, 2007 to September 30, 2008). (3) Date and notice of Annual General Meeting.
Nov 2008
28 Nov · Board meeting
Meeting of the Board of Directors of the Company was held on November 27, 2008, and was adjourned till November 28, 2008 at the same time and venue and that the Members at their meeting held on November 28, 2008, in addition to regular matters, have approved the appointment of Mr. Hemant V. Shah as Cost Auditor of the Company for the Financial Year 2008-2009.24 Nov · Board meeting
Inter alia to consider the appointment of Cost Auditor for the financial year 2008-09 and other items mentioned below: (1) To take a note of the resignation of Mr. Pankaj B. Gupta, the Company Secretary of the Company. (2) To consider authorising Mr. Ashok Shinkar - Director, Corporate Finance to sign the Share Certificate of the company. (3) To consider authorising Mr. Ashok Shinkar - Director, Corporate, Finance to sign the Dividend Warrants of the company. (4) To consider appointment of Cost Auditor of the Company for the financial year from October 01, 2008 to March 31, 2009. (5) To take a note of Compliance of Code of Conduct given by the Sr. Management Personnel of the Company. (6) Any other business with the permission of the Chair. The details of the agenda of the meeting shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
18 Jul · Board meeting
Inter alia to consider and take on record the Unaudited Financial Results of the Company for the fifth quarter and fifteen months ended as on June 30, 2008.
Jun 2008
19 Jun · Board meeting
Inter alia to consider Unaudited Financial Results of the Company for the fourth quarter and twelve months ended as on March 31, 2008. Further, the Company has submitted to the Exchange an announcement on the Order of Hon'ble Supreme Court in the matter of merger of The Pharmaceutical Products of India Limited with Wanbury Limited (the Company). A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2008
28 Apr · Board meeting
Board Members at their meeting held on April 28, 2008, in addition to regular matters, have approved the appointment of Mr. Hemant V. Shah as Cost Auditor of the Company for the Financial Year 2008-2009.23 Apr · Board meeting
Meeting of the Board of Directors of the Company will be held on April 28, 2008 inter alia to consider the appointment of Cost Auditor for the financial year 2008-2009. The details of the other Agenda items of the Meeting shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.